Track record

Pharmadule offers the fastest and most profitable way of implementing complete pharmaceutical or biopharmaceutical production facilities.

Sort by 

Biopharmaceutical API Facility

Eli Lilly & Co

Indianapolis, IN, USA

Completed: 2005

Biopharmaceutical API Facility

Scope: Fermentation, harvesting, purification, and bulk filling.

API Kilolab

Schwarz Pharma (aquired by UCB)

Shannon, Ireland

Completed: 2005

API Kilolab

Scope: Dispensing, reactor skids, filter dryer, heating, and cooling skids.

API Facility

Eli Lilly & Co

Cork, Ireland

Completed: 2005

API Facility

Scope: Crystalization, filtration, and milling/blending.

Biopharmaceutical API Facility

Eli Lilly & Co

Speke, United Kingdom

Completed: 2005

Biopharmaceutical API Facility

Scope: Buffer preparation, chromatography, purification and aseptic bulk filling. Dispensing, lockers, and API storage.

Aseptic Filling Facility

Baxter

Bloomington, IN, USA

Completed: 2005

Aseptic Filling Facility

Scope: Formulation, filling, inspection, and lyophilization.

Pharma Lab

Robert Bosch GmbH

Crailsheim, Germany

Completed: 2004

Pharma Lab

Scope: Modular Facility with HVAC.

Biopharmaceutical API Facility

Eli Lilly & Co

Carolina, Puerto Rico, USA

Completed: 2004

Biopharmaceutical API Facility

Scope: Buffer preparation, purification and vacuum drying, chromatography, ultrafiltration, high containment, and bulk filling in refrigerated area. Seismic zone 3.

Solid Dosage Facility

Merck & Co Inc.

Singapore (Tuas Park), Singapore

Completed: 2003

Solid Dosage Facility

Scope: Solvent preparation, high shear granulation, and fluid bed drying.

Aseptic Filling Facility

Vitrolife

Denver, USA

Completed: 2003

Aseptic Filling Facility

Scope: Formulation, sterile filtration and filling. Laboratory.

Solid Dosage Facility

Merck & Co Inc.

Henares de Alcala, Spain

Completed: 2002

Solid Dosage Facility

Scope: Dispensing, ribbon blending, mixing, roller compaction, tabletting and coating.

Page: 2 of 5 « Previous Next »